Association of family history with patient characteristics and prognosis in a large European gastroesophageal cancer cohort

Hannah C Puhr; Luzia Berchtold; Linda Zingerle; Melanie Felfernig; Lisa Weissenbacher; Gerd Jomrich; Reza Asari; Sebastian F Schoppmann; Gerald W Prager; Elisabeth S Bergen; Anna S Berghoff; Matthias Preusser; Aysegül Ilhan-Mutlu

doi:10.1007/s00508-024-02432-3

Association of family history with patient characteristics and prognosis in a large European gastroesophageal cancer cohort

Wien Klin Wochenschr. 2024 Sep 5. doi: 10.1007/s00508-024-02432-3. Online ahead of print.

Affiliations

¹ Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
² Institute for Medical Statistics, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
³ Department of Surgery, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
⁴ Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. aysegul.ilhan@meduniwien.ac.at.

PMID: 39235615
DOI: 10.1007/s00508-024-02432-3

Abstract

Introduction: The role of the family history in the development and prognosis of gastroesophageal cancer is a controversially discussed topic as appropriate data from western cohorts are lacking. This study aims to explore its associations with disease and outcome parameters in a large European cohort.

Methods: We retrospectively analyzed self-reported family history in patients with gastroesophageal cancer treated between 1 January 1990 and 31 December 2021 at the Medical University of Vienna. Association analyses with patient characteristics, tumor characteristics, symptoms and overall survival (OS) were performed.

Results: In our cohort of 1762 gastroesophageal cancer patients, 592 (34%) reported a positive family history of cancer (159, 9%, gastroesophageal cancer). No associations were found with histopathological parameters or initial symptoms; however, a positive family history correlated with female gender (cancer in general: p = 0.011; gastroesophageal cancer: p = 0.015). Family history of cancer in general was associated with earlier cancer stages (p = 0.04), higher BMI (p = 0.005), and alcohol consumption (p = 0.010), while a positive history for gastroesophageal cancer was associated with higher age at diagnosis (p = 0.002) and stomach cancer (p = 0.002). There was no statistically significant association of positive family history with OS (p = 0.1, p = 0.45), also not in subgroups for histology (adeno and squamous cell), number of family members and degree of relative.

Conclusion: Our results emphasize that a positive family history is neither statistically significantly associated with prognosis nor with specific histopathological features in patients with gastroesophageal cancer. Yet, associations with distinct patient characteristics and positive family history indicate that specific subgroups might profit from endoscopic surveillance. Prospective studies are warranted to investigate these findings further.

Keywords: Epidemiology; Esophageal cancer; Gastric cancer; Genetics; Hereditary.